Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation.
Saved in:
| Title: | Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation. |
|---|---|
| Authors: | Peer CJ; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Heiss BL; Department of Medicine, Section of Hematology/Oncology, and Committee on Clinical Pharmacology & Pharmacogenomics, The University of Chicago, Chicago, Illinois, USA., Goldstein DA; Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Goodell JC; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Ratain MJ; Department of Medicine, Section of Hematology/Oncology, and Committee on Clinical Pharmacology & Pharmacogenomics, The University of Chicago, Chicago, Illinois, USA. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2022 Apr; Vol. 62 (4), pp. 532-540. Date of Electronic Publication: 2022 Jan 05. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-4604 |
|---|---|
| DOI: | 10.1002/jcph.1984 |
